Journal article

Diverse mechanisms of PARP inhibitor resistance in ovarian cancer

Matthew John Wakefield, Ksenija Nesic, Olga Kondrashova, Clare L Scott

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer | ELSEVIER | Published : 2019

DOI: 10.1016/j.bbcan.2019.08.002

Related Projects (1)

Project icon

Provision of computational biology support for research by Melbourne Bioinformatics, MDHS, UoM to A/Prof Scott's lab of the Walter and Eliza Hall Institute of Medical Research.

Grants

Awarded by Australian National Health and Medical Research Council

Funding Acknowledgements

This work was supported by The Australian National Health and Medical Research Council (1062702) and The Stafford Fox Medical Research Foundation.

Citation metrics

5Web of Science
7Scopus
8Dimensions

Keywords

Brca2
Poly(adp-Ribose) Polymerase Inhibitors
Oncology
Life Sciences & Biomedicine
Biochemistry & Molecular Biology
Germline Mutations
Female
Replication Fork Reversal
Homologous Recombination
Humans
Biophysics
Stability
Science & Technology
Mutation
Drug Resistance, Neoplasm
Cell-Free Dna
Mutant-Cells
Antineoplastic Agents
Mre11-Dependent Degradation
Excision-Repair
Poly (adp-Ribose) Polymerase-1
Ovarian Neoplasms
Nascent Dna